文献速递肺外科

胸外科医生对肺切除术前戒烟的信念与实践

Thoracic Surgeons' Beliefs and Practices on Smoking Cessation Before Lung Resection.
PubMed 文献 · Ann Thorac Surg · 2018-12-23

该研究通过匿名调查846名参与胸外科医师学会普胸数据库的胸外科医生,探讨其对肺切除术前戒烟的信念与实践。结果显示,医生对是否应要求患者戒烟存在分歧,多数不强制要求戒烟,且极少转介戒烟项目或开具药物。

要点

  • 多数胸外科医生不强制要求肺切除术前戒烟。
  • 医生对要求戒烟的伦理性和结果公平性存在分歧。
  • 极少医生常规转介戒烟项目或开具尼古丁替代疗法。

核心结论

  • 胸外科医生对肺切除术前戒烟的信念和实践存在分歧。
  • 多数认为患者因素是戒烟的主要障碍,并担忧等待戒烟期间疾病进展。
  • 极少数医生常规转介戒烟项目并开具尼古丁替代疗法或药物治疗。

研究设计与样本

  • 匿名问卷通过电子邮件发送给846名参与胸外科医师学会普胸数据库的胸外科医生。
  • 应答率为23.6%(n=200)。

主要发现

  • 认为要求患者戒烟符合伦理的医生有96名(48%),认为结果受未戒烟患者影响公平的医生有87名(43.5%)。
  • 大多数医生(n=120,60%)不要求戒烟;要求戒烟的医生中最常见的戒烟时长要求为2周或以上。
  • 多数医生(n=160,80%)认为患者因素是戒烟的主要障碍。
  • 不要求戒烟的医生相比要求戒烟的医生,更关注疾病进展风险(39% vs 17.5%,p=0.02)和疏远患者(17.5% vs 8.8%,p=0.04)。
  • 仅19名(9.5%)医生总是转介戒烟项目并开具尼古丁替代疗法,仅9名(4.5%)医生总是转介项目并开具药物治疗。

临床怎么用

  • 胸外科医生应意识到术前戒烟管理存在实践差异,可考虑常规转介戒烟项目及药物治疗。
  • 对于等待戒烟期间疾病进展风险的担忧,需个体化权衡戒烟时机与手术紧迫性。

局限性

  • 应答率仅为23.6%,可能存在无应答偏倚。
  • 调查结果基于医生自我报告,可能不代表实际临床行为。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Smoking is a risk factor for complications after lung resection. Our primary aim was to ascertain thoracic surgeons' beliefs and practices on smoking cessation before lung resection. METHODS: An anonymous survey was emailed to 846 thoracic surgeons who participate in The Society of Thoracic Surgeons General Thoracic Surgery Database. RESULTS: The response rate was 23.6% (n = 200). Surgeons were divided when asked whether it is ethical to require that patients quit smoking (yes, n = 96 [48%]) and whether it is fair to have their outcomes affected by patients who do not quit (yes, n = 87 [43.5%]). Most do not require smoking cessation (n = 120 [60%]). Of those who require it, the most common required period of cessation is 2 weeks or more. Most believe that patient factors are the main barrier to quitting (n = 160 [80%]). Risk of disease progression (39% vs 17.5%, p = 0.02) and alienating patients (17.5% vs 8.8%, p = 0.04) were very important considerations of those who do not require smoking cessation versus those who do. Only 19 (9.5%) always refer to a smoking cessation program and prescribe nicotine replacement therapy and even fewer, 9 (4.5%), always refer to a program and prescribe medical therapy. CONCLUSIONS: Thoracic surgeons are divided on their beliefs and practices regarding smoking cessation before lung resection. Most believe patient factors are the main barrier to quitting and have concerns about disease progression while awaiting cessation. Very few surgeons refer to a smoking cessation program and prescribe nicotine replacement therapy or medical therapy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Marrufo AS, Kozower BD, Tancredi DJ, et al. Thoracic Surgeons' Beliefs and Practices on Smoking Cessation Before Lung Resection. Ann Thorac Surg. 2018. PMID: 30586576. doi:10.1016/j.athoracsur.2018.11.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。